Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.58M Buy
20,095
+11
+0.1% +$1.29K 0.48% 36
2026
Q1
$2.42M Sell
20,084
-5
-0% -$577 0.52% 32
2025
Q4
$2.11M Sell
20,089
-269
-1% -$25.3K 0.49% 36
2025
Q3
$1.71M Sell
20,358
-897
-4% -$73.9K 0.43% 38
2025
Q2
$1.68M Sell
21,255
-619
-3% -$49.2K 0.47% 36
2025
Q1
$1.96M Sell
21,874
-1,467
-6% -$137K 0.64% 32
2024
Q4
$2.32M Buy
23,341
+1,110
+5% +$114K 0.77% 28
2024
Q3
$2.52M Sell
22,231
-581
-3% -$69K 1.04% 23
2024
Q2
$2.82M Buy
22,812
+5
+0% +$644 1.25% 21
2024
Q1
$3.01M Buy
22,807
+22,743
+35,536% +$2.8M 1.37% 21
2023
Q4
$6.98K Sell
64
-821
-93% -$85.2K 0.01% 218
2023
Q3
$212K Sell
885
-23,028
-96% -$2.48M 0.11% 77
2023
Q2
$2.76M Buy
23,913
+5
+0% +$568 1.37% 20
2023
Q1
$2.54M Sell
23,908
-846
-3% -$91.3K 1.37% 20
2022
Q4
$2.75M Buy
24,754
+6
+0% +$613 1.61% 15
2022
Q3
$2.13M Sell
24,748
-770
-3% -$68.7K 1.34% 20
2022
Q2
$2.33M Sell
25,518
-220
-0.9% -$19.5K 1.2% 24
2022
Q1
$2.21M Sell
25,738
-598
-2% -$47.1K 1% 29
2021
Q4
$2.02M Sell
26,336
-1,269
-5% -$101K 0.79% 42
2021
Q3
$2.07M Sell
27,605
-3,100
-10% -$236K 0.89% 36
2021
Q2
$2.39M Sell
30,705
-4,018
-12% -$299K 1.06% 30
2021
Q1
$2.55M Sell
34,723
-2,561
-7% -$189K 1.27% 24
2020
Q4
$2.91M Sell
37,284
-269
-0.7% -$20.6K 1.62% 21
2020
Q3
$2.97M Buy
37,553
+1,230
+3% +$96.3K 2% 14
2020
Q2
$2.68M Buy
36,323
+545
+2% +$41K 2.69% 8
2020
Q1
$2.63M Buy
35,778
+137
+0.4% +$10.8K 2.86% 6
2019
Q4
$3.09M Buy
35,641
+2,309
+7% +$190K 2.74% 7
2019
Q3
$2.68M Buy
33,332
+1,479
+5% +$119K 2.68% 8
2019
Q2
$2.55M Sell
31,853
-309
-1% -$23.7K 2.68% 7
2019
Q1
$2.55M Sell
32,162
-47
-0.1% -$3.52K 2.75% 6
2018
Q4
$2.35M Buy
+32,209
New +$2.27M 2.91% 4

Other funds holding MRK

DAGCO Inc's MRK Position: Q2 2026 in Review

DAGCO Inc increased its Merck (MRK) stake by 0.05% in Q2 2026, buying an estimated $1.29K and bringing the position to 20,095 shares worth $2.58M. The position accounts for 0.48% of the portfolio, ranked #36.

DAGCO Inc first reported a position in MRK in Q4 2018 and has held it in 31 quarters since. The position peaked at $3.09M in Q4 2019. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • DAGCO Inc held 20,095 shares of Merck worth $2.58M as of Q2 2026.
  • DAGCO Inc bought 11 Merck shares in Q2 2026, an estimated $1.29K.
  • Merck made up 0.48% of DAGCO Inc's portfolio in Q2 2026, its #36 holding.
  • DAGCO Inc first reported a position in Merck in Q4 2018 and has held it in 31 quarters since.
  • DAGCO Inc's Merck position peaked at $3.09M in Q4 2019.
  • 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on DAGCO Inc's 13F filing for Q2 2026, filed 10 Jul 2026.